December 11, 2015 / 12:30 PM / 2 years ago

Teenage British junior champion admits EPO doping

LONDON (Reuters) - Fears that the use of performance-enhancing drugs in amateur cycling are on the rise increased with a confession by a British junior national champion to having used the banned blood booster EPO.

Eighteen year-old Gabriel Evans said in a statement on a time-trialling website and an interview with Cycling Weekly magazine that he had been tempted to dope after losing the national 25-mile time trial title in August and having watched a BBC documentary on doping.

“A lot of it was curiosity. On 3 August 2015 I bought EPO for the first time,” he wrote.

”On 11 August 2015 I traveled to France for a week’s training camp with the family of a then-team mate.

”With me I brought one vial of EPO. This was found by the teammate’s father who presented evidence to UK Anti-Doping.

“UKAD contacted me shortly after to arrange a deposition, in which I promptly admitted to all wrongdoing.”

Evans won the national junior 10-mile time trial in September but has subsequently been stripped of the title and dismissed by two amateur clubs, London Dynamo and Catford CC Equipe/Banks.

He has refused to say who supplied him with the EPO but offered a warning to anyone considering using performance enhancing drugs.

“Know that my choice has turned out to be immensely destructive,” he said.

UKAD have not yet revealed his punishment.

In a further blow to the sport, British Masters champions Andrew Hastings, 35, was banned on Thursday for using anabolic steroids despite coming up with a novel excuse.

Hastings tested positive at the National Time Trial Championships in May and the following day won the British Cycling Masters 35-39 age group title.

He said he had borrowed a used syringe from a stranger at a gym to inject a vitamin and that the steroids detected must have come from that needle.

Reporting by Steve Tongue, editing by Mitch Phillips

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below